Bowling Bao: Announcement on completion of the controlling shareholder\'s plan to transfer shares to those acting in concert
Bowling Bao: Announcement of Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders
Bao Ling Bao: Legal Opinion of Beijing Yongxing Law Firm on the 2024 Fourth Extraordinary General Meeting of Shareholders of Bolingbao Biotech Co., Ltd.
Bowling Bao: Pre-disclosure Notice for Shareholders Holding 5% or More of Their Shares to Reduce Their Shareholding
Bowling Bao: Announcement on the profit distribution plan for the first three quarters of 2024
Bowling Bao: Announcement of Supervisory Board Resolutions
Bowling Bao: Announcement of Board Resolutions
Bowling Bao: Report for the third quarter of 2024
Bowling Bao: Notice on Convening the Fourth Extraordinary General Meeting of Shareholders of the Company in 2024
Bowling Bao: Announcement on signing a strategic cooperation framework agreement with Qingdao Haizhiyuan Life Technology Co., Ltd.
Bowling Bao: Announcement on the freezing of some of the controlling shareholders\' shares due and awaiting the freeze to take effect
Bowling Bao: Announcement on plans for enterprises controlled by actual controllers to increase the company\'s stock holdings
Bowling Bao: 002286 Bowling Bao Investor Relations Management Information 20240910
Bowling Bao: Announcement on Some of the Controlling Shareholders\' Shares Waiting to Be Frozen
Baolingbao Biology: Peking Boxin Securities Investment Consultant Co., Ltd.'s financial adviser verification opinion on the detailed equity change report of Baolingbao Biology Co., Ltd.
Baolingbao Biology: Report on Changes in Equity Ownership
Baolingbao Biology: Announcement on progress of transfer of shareholdings by the controlling shareholder and signing of a joint action agreement.
Baolingbao Biology: Announcement on Pre-Disclosure of Controlling Shareholder's Proposed Transfer of Shares to the Consistent Acting Person and Equity Change
Baolingbao Biology: Announcement on the expiration and completion of the shareholding plan of some directors and senior management personnel.
Baolingbao Biology: Financial Report for the first half of 2024.
No Data
No Data